Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
NIH research grinds to a halt as government shuts down
The NIH will retain 4,477, or 24.54%, of its staff during the shutdown, primarily to maintain operations at the NIH Clinical Center.
Darren Incorvaia
Oct 1, 2025 12:12pm
FDA snubs Fortress' Zydus-partnered Menkes disease candidate
Oct 1, 2025 12:00pm
Irish biotech launches with $21M to shuttle RNAi meds to brain
Oct 1, 2025 10:34am
BMS, Takeda join peers in push to improve AI by pooling data
Oct 1, 2025 10:34am
White House pledges $100M to AI pediatric cancer project
Oct 1, 2025 11:06am
Kyorin pens $105M pact for Japan rights to Hinge's lupus drug
Oct 1, 2025 6:40am
More News
Fierce Pharma
Halozyme buys Elektrofi for up to $900M
Oct 1, 2025 2:36pm
Illumina launches AI informatics business for multi-omics data
Oct 1, 2025 11:30am
Siemens Healthineers’ MRIs see FDA recall over ice blockages
Oct 1, 2025 10:30am
Fierce Healthcare
Federal government enters shutdown, virtual care programs expire
Oct 1, 2025 8:30am
See more stories